Tag:
oncology research
Health
New Trial Aims to Transfo...
In a groundbreaking phase 1 clinical trial at City of Hope®, one of the largest and most advanced cancer research and treatment centers in the U.S., researchers are exploring an innovative approach to treating rectal cancer. The trial seeks to transform rectal cancer—a disease notorious for its resistance to radiation—into a form that is much more responsive to radiation and chemotherapy. This new strategy, which uses the investigational drug papaverine, could pave the way for less invasive treatment options and dramatically improve the quality of life for patients.
Health
Aston University Develops...
This blog post discusses the groundbreaking collaboration between Aston University and the Royal Orthopaedic Hospital in developing an innovative injectable paste for bone cancer treatment. The research focuses on using gallium-doped bioglass to enhance therapeutic efficacy while minimizing side effects. By delivering targeted therapy directly to tumor sites, this advancement aims to improve patient outcomes, reduce recurrence rates, and expedite recovery times. This interdisciplinary effort symbolizes a significant leap in oncology care, offering hope for better treatment solutions and improved quality of life for bone cancer patients.
Science
Exploring the Dana-Farber...
Explore the groundbreaking Radioligand Program developed by Dana-Farber Cancer Institute and Gustave Roussy, aimed at revolutionizing cancer treatment. This initiative focuses on the application of radioligands for targeted therapy, improving patient outcomes with reduced side effects. Join experts like Professors Toni Choueiri and Karim Fizazi at the 'Radiopharmaceutical Therapy Meets Oncology' conference to learn about advancements in precision oncology, clinical applications, and the role of collaborative initiatives in cancer care. Stay informed on the latest research and treatments transforming the oncology landscape.
Health
The Surprising Role of th...
Explore the groundbreaking research on the cdkn2a gene and its dual role in esophageal cancer. Learn how this gene, previously viewed solely as a tumor suppressor, may also provide protective mechanisms in early cancer development. This blog post delves into recent findings, implications for cancer prognostics, and future directions in cancer therapy and prevention strategies.